Citation: Yi Wang, Fei Li, Hui Xu, Yiliang Fu, Guoshuang Feng, Hanwen Zhang, Juan Huang, Zhengde Xie, Xiangpeng Chen. The epidemiology and disease burden of enterovirus infections among hospitalized children in China: An 8-year national cross-sectional study .VIROLOGICA SINICA, 2026, 41(3) : 513-522.  http://dx.doi.org/10.1016/j.virs.2026.05.011

The epidemiology and disease burden of enterovirus infections among hospitalized children in China: An 8-year national cross-sectional study

  • Corresponding author: Xiangpeng Chen, chenxp1111@163.com
  • Received Date: 05 September 2025
    Accepted Date: 29 May 2026
    Available online: 03 June 2026
  • Enterovirus (EV) infections represent a significant global and national health concern in children, leading to various complications. Although most children with EV infections generally have a favorable prognosis, a small proportion may still develop severe complications. This study aimed to analyze the epidemiological characteristics, disease spectrum, and disease burden of EV infections in China. A total of 163,714 hospitalized children with EV infections from 37 member hospitals of the Futang Research Center of Pediatric Development were identified between Jan 1st, 2016 and Dec 31st, 2023, accounting for 1.49% of all pediatric hospitalizations. Most cases occurred in infants aged 28 days to ≤ 1 year (42.29%) and toddlers aged 1 to ≤ 3 years (39.93%), with a male predominance (male-to-female ratio, 1.62 : 1). Severe cases of EV infections can be life-threatening and increase the burden of disease. The median LOS for EV infections were 5 days, with an average hospitalization cost of $587.37. EV infections can affect multiple organs, including the heart, brain, and respiratory system and were associated with severe complications, including myocarditis, encephalitis, and meningitis. These findings underscore the substantial disease burden of EV infections and highlight the need for targeted prevention strategies in young children.

  • 加载中
    1. Bello AM, Roshorm YM, 2022. Recent progress and advances towards developing enterovirus 71 vaccines for effective protection against human hand, foot and mouth disease (hfmd). Biologicals. 79, 1-9.

    2. Chuang YY, Huang YC, 2019. Enteroviral infection in neonates. J Microbiol Immunol Infect. 52, 851-857.

    3. Compagnoli Carmona RC, Caetano Machado B, Aparecida de Sousa C, Vieira HR, Moraes Alves MR, Farias de Souza KA, de Souza Gregorio D, Costa Vilanova B, Sampaio Tavares Timenetsky MDC, 2020. Distribution of species enterovirus b in patients with central nervous system infections in sao paulo state, brazil. J Med Virol. 92, 3849-3856.

    4. Gao F, Tang BC, Jiang XL, Yin SY, Chang ZR, Qin Y, Li Y, Li ZJ, 2024. Epidemiological characteristics and trend of mortality on hand, foot and mouth disease in china, 2008-2022. Zhonghua Liu Xing Bing Xue Za Zhi. 45, 1626-1632. (in Chinese).

    5. Gao F, Bian LL, Chen L, Zhou YP, Li GF, Mao QY, He Q, Wu X, Yao SS, Yang XM, Liang ZL, 2021. A cross-sectional seroepidemiology study of seven major enteroviruses causing hfmd in guangdong, china. J Infect. 83, 119-145.

    6. Guan D, van der Sanden S, Zeng H, Li W, Zheng H, Ma C, Su J, Liu Z, Guo X, Zhang X, Liu L, Koopmans M, Ke C, 2012. Population dynamics and genetic diversity of c4 strains of human enterovirus 71 in mainland china, 1998-2010. PLoS One. 7, e44386.

    7. Halabi KC, Stockwell MS, Alba L, Vargas C, Reed C, Saiman L, 2022. Clinical and socioeconomic burden of rhinoviruses/enteroviruses in the community. Influenza Other Respir Viruses. 16, 891-896.

    8. Han Y, Ji H, Shen W, Duan C, Cui T, Chen L, Hang H, Zhang Z, Sun H, Zhang X, Jin H, 2022. Disease burden in patients with severe hand, foot, and mouth disease in jiangsu province: A cross-sectional study. Hum Vaccin Immunother. 18, 2049168.

    9. Han Z, Song Y, Xiao J, Jiang L, Huang W, Wei H, Li J, Zeng H, Yu Q, Li J, Yu D, Zhang Y, Li C, Zhan Z, Shi Y, Xiong Y, Wang X, Ji T, Yang Q, Zhu S, Yan D, Xu W, Zhang Y, 2020. Genomic epidemiology of coxsackievirus a16 in mainland of china, 2000-18. Virus Evol. 6, veaa084.

    10. Harvala H, Benschop KSM, Berginc N, Midgley S, Wolthers K, Simmonds P, Feeney S, Bailly JL, Mirand A, Fischer TK, On Behalf Of The Enpen Hospital-Based Surveillance N, 2021. European non-polio enterovirus network: Introduction of hospital-based surveillance network to understand the true disease burden of non-polio enterovirus and parechovirus infections in europe. Microorganisms. 9, 1827.

    11. Hong J, Liu F, Qi H, Tu W, Ward MP, Ren M, Zhao Z, Su Q, Huang J, Chen X, Le J, Ren X, Hu Y, Cowling B, Li Z, Chang Z, Zhang Z, 2022. Changing epidemiology of hand, foot, and mouth disease in china, 2013-2019: A population-based study. Lancet Reg Health West Pac. 20, 100370.

    12. Jartti M, Flodstrom-Tullberg M, Hankaniemi MM, 2024. Enteroviruses: Epidemic potential, challenges and opportunities with vaccines. J Biomed Sci. 31, 73.

    13. Jiang L, Jiang H, Tian X, Xia X, Huang T, 2021. Epidemiological characteristics of hand, foot, and mouth disease in yunnan province, china, 2008-2019. BMC Infect Dis. 21, 751.

    14. Jin Y, Zhang R, Wu W, Duan G, 2018. Innate immunity evasion by enteroviruses linked to epidemic hand-foot-mouth disease. Front Microbiol. 9, 2422.

    15. Jmii H, Fisson S, Aouni M, Jaidane H, 2021. Type b coxsackieviruses and central nervous system disorders: Critical review of reported associations. Rev Med Virol. 31, e2191.

    16. Kinobe R, Wiyatno A, Artika IM, Safari D, 2022. Insight into the enterovirus a71: A review. Rev Med Virol. 32, e2361.

    17. Li Y, Zhou Y, Cheng Y, Wu P, Zhou C, Cui P, Song C, Liang L, Wang F, Qiu Q, Guo C, Zeng M, Long L, Cowling BJ, Yu H, 2019. Effectiveness of ev-a71 vaccination in prevention of paediatric hand, foot, and mouth disease associated with ev-a71 virus infection requiring hospitalisation in henan, china, 2017-18: A test-negative case-control study. Lancet Child Adolesc Health. 3, 697-704.

    18. Liu F, Yi Y, Song Y, Zhang X, Xie T, Liu Y, Chen Y, Huang S, Zhang J, Zhang Y, Chang Z, Cui F, 2025. Epidemiology of hand, foot, and mouth disease outbreaks before and during availability of ev-a71 vaccine in china's mainland: Analysis of outbreak surveillance data from 2011 to 2023. Lancet Reg Health West Pac. 59, 101603.

    19. Lloyd RE, Tamhankar M, Lernmark A, 2022. Enteroviruses and type 1 diabetes: Multiple mechanisms and factors? Annu Rev Med. 73, 483-499.

    20. Mai CTN, Ly LTK, Doan YH, Oka T, Mai LTP, Quyet NT, Mai TNP, Thiem VD, Anh LT, Van Sanh L, Hien ND, Anh DD, Parashar UD, Tate JE, Van Trang N, 2023. Prevalence and characterization of gastroenteritis viruses among hospitalized children during a pilot rotavirus vaccine introduction in vietnam. Viruses. 15, 2164.

    21. Messacar K, Spence-Davizon E, Osborne C, Press C, Schreiner TL, Martin J, Messer R, Maloney J, Burakoff A, Barnes M, Rogers S, Lopez AS, Routh J, Gerber SI, Oberste MS, Nix WA, Abzug MJ, Tyler KL, Herlihy R, Dominguez SR, 2020. Clinical characteristics of enterovirus a71 neurological disease during an outbreak in children in colorado, USA, in 2018: An observational cohort study. Lancet Infect Dis. 20, 230-239.

    22. Pons-Salort M, Parker EP, Grassly NC, 2015. The epidemiology of non-polio enteroviruses: Recent advances and outstanding questions. Curr Opin Infect Dis. 28, 479-487.

    23. Puenpa J, Wanlapakorn N, Vongpunsawad S, Poovorawan Y, 2019. The history of enterovirus a71 outbreaks and molecular epidemiology in the asia-pacific region. J Biomed Sci. 26, 75.

    24. Rankin DA, Spieker AJ, Perez A, Stahl AL, Rahman HK, Stewart LS, Schuster JE, Lively JY, Haddadin Z, Probst V, Michaels MG, Williams JV, Boom JA, Sahni LC, Staat MA, Schlaudecker EP, McNeal MM, Harrison CJ, Weinberg GA, Szilagyi PG, Englund JA, Klein EJ, Gerber SI, McMorrow M, Rha B, Chappell JD, Selvarangan R, Midgley CM, Halasa NB, 2023. Circulation of rhinoviruses and/or enteroviruses in pediatric patients with acute respiratory illness before and during the covid-19 pandemic in the us. JAMA Netw Open. 6, e2254909.

    25. Sun Y, Zhou J, Nie W, Tian D, Ye Q, 2024. Study on the epidemiological characteristics of enterovirus among pediatric patients in hangzhou, china: A comparison between the pre-covid-19, covid-19 pandemic, and post-covid-19 periods. J Med Virol. 96, e29412.

    26. Tarris G, de Rougemont A, Charkaoui M, Michiels C, Martin L, Belliot G, 2021. Enteric viruses and inflammatory bowel disease. Viruses. 13, 104.

    27. Tomatis Souverbielle C, Erdem G, Sanchez PJ, 2023. Update on nonpolio enterovirus and parechovirus infections in neonates and young infants. Curr Opin Pediatr. 35, 380-389.

    28. Uprety P, Graf EH, 2020. Enterovirus infection and acute flaccid myelitis. Curr Opin Virol. 40, 55-60.

    29. Uprety P, Curtis D, Elkan M, Fink J, Rajagopalan R, Zhao C, Bittinger K, Mitchell S, Ulloa ER, Hopkins S, Graf EH, 2019. Association of enterovirus d68 with acute flaccid myelitis, philadelphia, pennsylvania, USA, 2009-2018. Emerg Infect Dis. 25, 1676-1682.

    30. Wang C, Huang M, Guo B, Zhou X, Cui Z, Xu Y, Ren Y, 2025. Severe enterovirus a71 infection is associated with dysfunction of t cell immune response and alleviated by astragaloside a. Virol Sin. 40, 451-461.

    31. Wu H, Xue M, Wu C, Lu Q, Ding Z, Wang X, Fu T, Yang K, Lin J, 2022. Trend of hand, foot, and mouth disease from 2010 to 2021 and estimation of the reduction in enterovirus 71 infection after vaccine use in zhejiang province, china. PLoS One. 17, e0274421.

    32. Xie L, Huang R, Wang H, Liu S, 2021. Spatial-temporal heterogeneity and meteorological factors of hand-foot-and-mouth disease in xinjiang, china from 2008 to 2016. PLoS One. 16, e0255222.

    33. Yang J, Liao Q, Luo K, Liu F, Zhou Y, Zou G, Huang W, Yu S, Wei X, Zhou J, Dai B, Qiu Q, Altmeyer R, Hu H, Paireau J, Luo L, Gao L, Nikolay B, Hu S, Xing W, Wu P, van Doorn HR, Horby PW, Simmonds P, Leung GM, Cowling BJ, Cauchemez S, Yu H, 2022. Seroepidemiology of enterovirus a71 infection in prospective cohort studies of children in southern china, 2013-2018. Nat Commun. 13, 7280.

    34. Zell R, Delwart E, Gorbalenya AE, Hovi T, King AMQ, Knowles NJ, Lindberg AM, Pallansch MA, Palmenberg AC, Reuter G, Simmonds P, Skern T, Stanway G, Yamashita T, Ictv Report C, 2017. Ictv virus taxonomy profile: Picornaviridae. J Gen Virol. 98, 2421-2422.

    35. Zhang H, Lai X, Mak J, Sriudomporn S, Zhang H, Fang H, Patenaude B, 2022. Coverage and equity of childhood vaccines in china. JAMA Netw Open. 5, e2246005.

    36. Zhang M, Wang H, Tang J, He Y, Xiong T, Li W, Qu Y, Mu D, 2021. Clinical characteristics of severe neonatal enterovirus infection: A systematic review. BMC Pediatr. 21, 127.

    37. Zhou T, Hu H, Gao J, Yu H, Jit M, Wang P, 2024. Health-related quality of life and economic burden among hospitalized children with hand, foot, and mouth disease: A multiregional study in china. Pharmacoecon Open. 8, 459-469.

    38. Zhu Z, Feng Y, Gu L, Guan X, Liu N, Zhu X, Gu H, Cai J, Li X, 2023. Spatio-temporal pattern and associate factors of intestinal infectious diseases in zhejiang province, china, 2008-2021: A bayesian modeling study. BMC Public Health. 23, 1652.

  • 加载中

Figures(1)

Article Metrics

Article views(19) PDF downloads(0) Cited by()

Related
Proportional views

    The epidemiology and disease burden of enterovirus infections among hospitalized children in China: An 8-year national cross-sectional study

      Corresponding author: Xiangpeng Chen, chenxp1111@163.com
    • a. Beijing Key Laboratory of Core Technologies for the Prevention and Treatment of Emerging Infectious Diseases in Children, Key Laboratory of Major Diseases in Children, Ministry of Education, National Clinical Research Center for Respiratory Diseases, Research Unit of Critical Infection in Children, Chinese Academy of Medical Sciences, Laboratory of Infection and Virology, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China;
    • b. Big Data Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China

    Abstract: Enterovirus (EV) infections represent a significant global and national health concern in children, leading to various complications. Although most children with EV infections generally have a favorable prognosis, a small proportion may still develop severe complications. This study aimed to analyze the epidemiological characteristics, disease spectrum, and disease burden of EV infections in China. A total of 163,714 hospitalized children with EV infections from 37 member hospitals of the Futang Research Center of Pediatric Development were identified between Jan 1st, 2016 and Dec 31st, 2023, accounting for 1.49% of all pediatric hospitalizations. Most cases occurred in infants aged 28 days to ≤ 1 year (42.29%) and toddlers aged 1 to ≤ 3 years (39.93%), with a male predominance (male-to-female ratio, 1.62 : 1). Severe cases of EV infections can be life-threatening and increase the burden of disease. The median LOS for EV infections were 5 days, with an average hospitalization cost of $587.37. EV infections can affect multiple organs, including the heart, brain, and respiratory system and were associated with severe complications, including myocarditis, encephalitis, and meningitis. These findings underscore the substantial disease burden of EV infections and highlight the need for targeted prevention strategies in young children.

    Figure (1)  Reference (38) Relative (20)

    目录

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return